Literature DB >> 12447815

[A neuropsychological and behavioural profile of attention deficits in fragile X syndrome].

K Cornish1, F Munir, J Wilding.   

Abstract

INTRODUCTION: Fragile X syndrome is a well-recognised cause of developmental delay in males and to a lesser extent females. The aim of the present study was to present a detailed cognitive and behaviour analysis of the core attention impairments frequently associated with fragile X. PATIENTS AND METHODS: Two complementary studies were conducted. Study 1 examined the severity and range of behavioural problems in a group of 25 fragile X boys with fragile X compared with five control groups: a learning disabled comparison group (Down's syndrome-Trisomy 21) and four groups of normal developing control children. Two well validated rating scales were used as measures of behaviour: Study 2 examined performance by the above groups on a novel computerised task of attention that measured the ability to inhibit irrelevant responses.
RESULTS: Findings from Study 1 revealed that fragile X children were significantly more hyperactive, inattentive and impulsive in comparison with the Down's syndrome children but not in comparison to the poor attention control groups. The findings from Study 2 revealed that the main impairment in fragile X was in inhibiting repetition of successful responses and in switching attention from one type of response to another in a sequence, whether it has been successful or not.
CONCLUSION: Emerging evidence now supports the hypothesis that the fundamental deficit in fragile X is in controlling the flow of sequences of input and output. It is suggested that this control require inhibition.

Entities:  

Mesh:

Year:  2001        PMID: 12447815

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  17 in total

1.  The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome.

Authors:  Jose Luis Olmos-Serrano; Joshua G Corbin; Mark P Burns
Journal:  Dev Neurosci       Date:  2011-11-08       Impact factor: 2.984

2.  Emotion recognition and visual-scan paths in Fragile X syndrome.

Authors:  Tracey A Shaw; Melanie A Porter
Journal:  J Autism Dev Disord       Date:  2013-05

3.  Effects of labeling and pointing on object gaze in boys with fragile X syndrome: an eye-tracking study.

Authors:  David P Benjamin; Ann M Mastergeorge; Andrea S McDuffie; Sara T Kover; Randi J Hagerman; Leonard Abbeduto
Journal:  Res Dev Disabil       Date:  2014-07-23

4.  Fragile X mental retardation protein has a unique, evolutionarily conserved neuronal function not shared with FXR1P or FXR2P.

Authors:  R Lane Coffee; Charles R Tessier; Elvin A Woodruff; Kendal Broadie
Journal:  Dis Model Mech       Date:  2010-05-04       Impact factor: 5.758

Review 5.  Epigenetics and biomarkers in the staging of neuropsychiatric disorders.

Authors:  Trevor Archer; Richard J Beninger; Tomas Palomo; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

6.  Outcome measures for clinical trials in fragile X syndrome.

Authors:  Elizabeth Berry-Kravis; David Hessl; Leonard Abbeduto; Allan L Reiss; Andrea Beckel-Mitchener; Tiina K Urv
Journal:  J Dev Behav Pediatr       Date:  2013-09       Impact factor: 2.225

7.  Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice.

Authors:  Aimee V Franklin; Margaret K King; Valle Palomo; Ana Martinez; Lori L McMahon; Richard S Jope
Journal:  Biol Psychiatry       Date:  2013-09-13       Impact factor: 13.382

8.  Prepulse inhibition in fragile X syndrome: feasibility, reliability, and implications for treatment.

Authors:  David Hessl; Elizabeth Berry-Kravis; Lisa Cordeiro; Jennifer Yuhas; Edward M Ornitz; Aaron Campbell; Elizabeth Chruscinski; Crystal Hervey; James M Long; Randi J Hagerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-06-05       Impact factor: 3.568

9.  Towards a neurodevelopmental model of clinical case formulation.

Authors:  Marjorie Solomon; David Hessl; Sufen Chiu; Emily Olsen; Robert L Hendren
Journal:  Psychiatr Clin North Am       Date:  2009-03

10.  Lithium treatment alleviates impaired cognition in a mouse model of fragile X syndrome.

Authors:  M K King; R S Jope
Journal:  Genes Brain Behav       Date:  2013-08-29       Impact factor: 3.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.